Eric Aguiar is Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have made 13 open-market trades across 3 companies since 2016, most recently 2026-06-22.
CIK 0001262325
3 open-market purchases totalling $110.1M since 2016, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVTA | SELL | 2020-12-16 | 2020-12-18 | $51.00 | $510K | -11.1% | +18.7% | -15.7% |
| NVTA | SELL | 2020-11-16 | 2020-11-18 | $46.52 | $2.8M | +9.8% | +4.1% | +7.4% |
| NVTA | SELL | 2020-07-15 | 2020-07-16 | $33.99 | $680K | -11.3% | -4.6% | +47.8% |
| BHVN | SELL · 10b5-1 | 2020-01-22 | 2020-01-24 | $56.48 | $114K | +2.0% | -15.8% | -16.3% |
| BHVN | SELL | 2020-01-09 | 2020-01-10 | $56.39 | $1.7M | -1.2% | -16.9% | -36.0% |
| BHVN | SELL | 2019-12-16 | 2019-12-18 | $55.13 | $390K | +3.9% | +6.9% | -41.8% |
| BHVN | SELL | 2019-12-09 | 2019-12-11 | $55.11 | $449K | +5.5% | +10.7% | -14.0% |
| BHVN | SELL | 2019-11-20 | 2019-11-22 | $52.20 | $351K | -5.1% | -4.5% | -19.0% |
| BHVN | SELL | 2019-11-20 | 2019-11-22 | $52.46 | $772K | -5.1% | -4.5% | -19.0% |
| BHVN | SELL | 2019-09-11 | 2019-09-13 | $45.00 | $450K | -7.8% | -9.2% | +7.4% |
| EIDX | BUY | 2019-07-03 | 2019-07-08 | $29.90 | $52.8M | -1.3% | -13.9% | +5.8% |
| EIDX | BUY | 2019-05-24 | 2019-05-29 | $25.93 | $57.2M | -4.5% | -3.0% | +40.6% |
| NVTA | SELL | 2018-11-27 | 2018-11-28 | $13.50 | $135K | -11.2% | -27.4% | +39.9% |
| NVTA | BUY | 2016-11-18 | 2016-11-21 | $6.28 | $63K | -1.3% | +3.7% | +45.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.